11990245

Source:http://linkedlifedata.com/resource/pubmed/id/11990245

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0010181, umls-concept:C0069717, umls-concept:C0087111, umls-concept:C0123931, umls-concept:C0205179, umls-concept:C0205210, umls-concept:C0332120, umls-concept:C0439831, umls-concept:C0677667, umls-concept:C1280519, umls-concept:C1527249, umls-concept:C1955832
pubmed:issue	25
pubmed:dateCreated	2002-5-6
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9706284
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic, http://linkedlifedata.com/resource/pubmed/chemical/Camptothecin, http://linkedlifedata.com/resource/pubmed/chemical/Organoplatinum Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Quinazolines, http://linkedlifedata.com/resource/pubmed/chemical/Thiophenes, http://linkedlifedata.com/resource/pubmed/chemical/irinotecan, http://linkedlifedata.com/resource/pubmed/chemical/oxaliplatin, http://linkedlifedata.com/resource/pubmed/chemical/raltitrexed
pubmed:status	MEDLINE
pubmed:issn	1366-5278
pubmed:author	pubmed-author:BansbackNN, pubmed-author:HummelSS, pubmed-author:Lloyd JonesMM, pubmed-author:OrrBB, pubmed-author:SeymourMM
pubmed:issnType	Print
pubmed:volume	5
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1-128
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:11990245-Antimetabolites, Antineoplastic, pubmed-meshheading:11990245-Antineoplastic Agents, pubmed-meshheading:11990245-Antineoplastic Agents, Phytogenic, pubmed-meshheading:11990245-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:11990245-Camptothecin, pubmed-meshheading:11990245-Colorectal Neoplasms, pubmed-meshheading:11990245-Cost-Benefit Analysis, pubmed-meshheading:11990245-Drug Costs, pubmed-meshheading:11990245-England, pubmed-meshheading:11990245-Humans, pubmed-meshheading:11990245-Organoplatinum Compounds, pubmed-meshheading:11990245-Quality of Life, pubmed-meshheading:11990245-Quinazolines, pubmed-meshheading:11990245-Randomized Controlled Trials as Topic, pubmed-meshheading:11990245-Survival Analysis, pubmed-meshheading:11990245-Thiophenes, pubmed-meshheading:11990245-Treatment Outcome, pubmed-meshheading:11990245-Wales
pubmed:year	2001
pubmed:articleTitle	A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer.
pubmed:affiliation	School of Health and Related Research, University of Sheffield, UK.
pubmed:publicationType	Journal Article, Review, Research Support, Non-U.S. Gov't